Chemomab Therapeutics Ltd. (CMMB)
Nasdaq: CMMB · Pharmaceutical Preparations · Tel Aviv · filing with the SEC since 2011
Who owns Chemomab Therapeutics Ltd.
As filed with the SECHolders of 5% or more
2
HBM Healthcare Investments (Cayman) Ltd. holds 12.5% of Ordinary shares, no par value per share, as its SCHEDULE 13D/A filed Sep 9, 2026 says.
Directors and officers
9
report now, of 32 people on the record since 2019. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 2 named at left.
Holders of 5% or moreshare of the class, as filed
HBM Healthcare Investments (Cayman) Ltd.
SCHEDULE 13D/A · filed Sep 9, 2026 · Ordinary shares, no par value per share · 12.5% in Jul 16, 2026
Touchstone Global Investments Pty Ltd
SCHEDULE 13G · filed Aug 13, 2026 · American Depositary Shares, each representing 80 Ordinary Shares, no par value
Orbimed Israel Biofund Gp Limited Partnership
SCHEDULE 13D/A · filed Jun 23, 2025 · Ordinary Shares, no par value. American Depository Shares, each of which represents twenty Ordinary Shares, no par value · reported falling below 5%
Sphera Funds Management Ltd.
SCHEDULE 13G/A · filed Apr 10, 2025 · American Depository Shares, each representing twenty (20) ordinary shares, no par value · reported falling below 5%
Peter Thiel
SCHEDULE 13G/A · filed Feb 17, 2026 · Ordinary shares, no par value per share · reported falling below 5%
Morgan Stanley
SCHEDULE 13G/A · filed Aug 7, 2025 · Ordinary Shares / American Depositary Shares · reported falling below 5%, from 8.4% in Aug 7, 2025
Otto Erik
SCHEDULE 13G/A · filed Aug 10, 2026 · American Depository Shares, each of which represent twenty ordinary shares, no par value · reported falling below 5%, from 6.3% in Feb 10, 2026
What CMMB reports owning in othersstakes of 5% or more, and other ties
Chemomab Therapeutics Ltd. reports no stake in another company in the record.
Insider tradesForm 4
2sales
2purchases
0sales on a scheduled plan
1people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Sep 30, 2025 to Sep 30, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Sep 30, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window2 of 41 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Mor George Adi | Chief Executive Officer | 0 | $0 | 0 | 2 | $0 |
| Cohen Neil Harris | interim CEO | 2 | $0 | 0 | 0 | $0 |